Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3277 of 6351
-
Music as medicine: virtual therapy shows promise for Alzheimer's memory loss
Symptom relief Recruiting nowThis study is designed to assess the feasibility that individualized reminiscence-based virtual music therapy sessions can enhance autobiographical memory, mood, and cognition in patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's Disease (AD). 60 p…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New heart stent study aims for safer artery treatment
Disease control By invitation onlyIn this study, the investigators evaluated the effectiveness and safety of using the GENOSS® DES, which has a biodegradable polymer only on the inner wall of the blood vessel, for patients(all-comers) with coronary artery disease who require percutaneous coronary intervention thr…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
MS patients try new combo: gym classes then App-Based home workouts
Symptom relief OngoingThe aim of the study is to determine the benefits of outpatient group rehabilitation with subsequent telerehabilitation. The patient will participate in a 12-week circuit training, including training once a week in a group of six under the guidance of two physiotherapists. After …
Sponsor: Brno University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Brain scans reveal best Anti-Vaping ads to stop young vapers from smoking
Knowledge-focused Recruiting now180 young adult vapers who are not current smokers will participate in a baseline functional magnetic resonance imaging (fMRI) experiment, prospectively linked to a 1-year randomized controlled trial. Baseline fMRI tasks will probe critical neurocognitive markers with high potent…
Sponsor: University of Georgia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Natural annatto compound tested for statin muscle aches
Symptom relief Recruiting nowTo evaluate the effects of 3-months annatto-derived geranylgeraniol (GG) supplementation on statin-associated skeletal muscle health.
Phase 1/2 • Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Jun 26, 2026 16:39 UTC
-
Fish oil for autism: new study tests if Omega-3s calm behavior
Symptom relief Recruiting nowThis is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).
Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
New program eases burden for dementia caregivers
Symptom relief CompletedBased on preliminary work, whereby investigators examined pain management challenges and needs of caregivers of hospice patients with dementia, this team designed a cognitive behavioral intervention informed by the relational model of stress, entitled ENCODE (Empowering Caregiver…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Fish oil may shield cancer patients from chemo nerve pain
Prevention Recruiting nowThe purpose of this study is to examine the effect of supplementary polyunsaturated fatty acids on nerve damage in the body's extremitites of patients treated with oxaliplatin containing chemotherapy after surgery for colorectal cancer.
Sponsor: Vejle Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
New hospital tool aims to tame blood sugar chaos
Disease control Recruiting nowThe purpose of this study is to determine the impact of an electronic medical record clinical decision support tool on rates of dysglycemia in the hospital, and its clinical and economical outcomes. The study also evaluates the perspectives of providers regarding the tool's usefu…
Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New family program aims to ease ADHD symptoms with healthy routines
Symptom relief CompletedThe investigators have developed BUILT in hopes of empowering families to adopt and sustain healthy food, sleep, and exercise routines that optimize child focus, attention, and behavior. Over 6-weeks, the BUILT program will explore what science says about the effects of sleep, nu…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New study offers hope for dementia caregivers: talk therapy may ease stress and improve sleep
Symptom relief Recruiting nowThe purpose of this research study is to better understand how stress, sleep and activity might impact caregivers' mood and brain health. This study includes a randomized experimental component where therapists will systematically deliver one of two evidence-based talk-therapy tr…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Writing away the pain: new study tests expressive helping for cancer survivors
Symptom relief OngoingThe Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.
Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Light therapy app aims to ease dry mouth for cancer survivors
Symptom relief Recruiting nowThe Photobiomodulation therapy could have positive effects on quality of life and oral health in head and neck cancer survivors post-radiotherapy. The improvement in quality of life will be maintained after a follow-up period.
Sponsor: Universidad de Granada • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New drug shows promise in reducing lung scarring in small trial
Disease control CompletedThis is a Phase 2a, single -center, randomized, double-blind, placebo-controlled study to evaluate type 1 collagen deposition in the lungs following once-daily treatment with PLN-74809 for 12-weeks. This study is occurring at Massachusetts General Hospital.
Phase 2 • Sponsor: Pliant Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Brain study seeks to unravel loneliness in mental illness
Knowledge-focused Recruiting nowThe proposed research will test the hypothesis that objective social isolation and loneliness are linked to neurobehavioral mechanisms involved in social perception and motivation in individuals with and without serious mental illness. Moreover, it will investigate the specific d…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Could a common blood thinner help fight ovarian cancer?
Disease control Recruiting nowBackground: Previous findings have indicated antineoplastic properties of tinzaparin (Innohep®), a commonly used anti-coagulant. Earlier studies have mainly investigated the antineoplastic effects of tinzaparin in animal models and in human cell-lines. In this pilot study the ai…
Phase 2 • Sponsor: University Hospital, Linkoeping • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Virtual reality could help measure and treat cancer pain, study suggests
Knowledge-focused Stopped earlyThis study aims to develop objective tools for assessing perceived pain severity in cancer patients and survivors, evaluate the sustained effectiveness of non-pharmacological interventions such as virtual reality in reducing pain and medication use, and create tools for the early…
Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Pompe disease patients get continued enzyme therapy in Long-Term safety study
Disease control OngoingThis long-term open label safety and efficacy study is intended to follow up, and to provide post-trial access to ERT with avalglucosidase alfa to patients with Pompe disease in France who have completed Study EFC14028, LTS13769, or ACT14132, from market authorization until the c…
Phase 4 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Sep 10, 2026 12:00 UTC
-
Experimental pill aims to rev up immune system against Hard-to-Treat tumors
Disease control Recruiting nowRBS2418 (investigational product) is a specific immune modulator, working through ectonucleotide pyrophosphatase/phosphodiesterase I (ENPP1), designed to lead to anti-tumor immunity by increasing endogenous 2'-3'-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) and …
Phase 1 • Sponsor: Riboscience, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Mindfulness machine: new device may ease anxiety without pills
Symptom relief CompletedThis randomized controlled trial compared the effectiveness of a 10-day mindfulness training program using adaptive biofeedback (BFB) versus medication therapy (escitalopram 10 mg/day) versus combined treatment (BFB + medication) in inpatients with anxiety disorders (ICD-10 F40/F…
Phase 4 • Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC